Obstructive sleep apnea therapy for cardiovascular risk reduction—Time for a rethink?

Obstructive sleep apnea (OSA) is a highly prevalent and underdiagnosed medical condition, which is associated with various cardiovascular and metabolic diseases. The current mainstay of therapy is continuous positive airway pressure (CPAP); however, CPAP is known to be poorly accepted and tolerated...

Descripción completa

Detalles Bibliográficos
Autores principales: Dissanayake, Hasthi U., Colpani, Juliana T., Sutherland, Kate, Loke, Weiqiang, Mohammadieh, Anna, Ou, Yi‐Hui, de Chazal, Philip, Cistulli, Peter A., Lee, Chi‐Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715402/
https://www.ncbi.nlm.nih.gov/pubmed/34791676
http://dx.doi.org/10.1002/clc.23747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715402/
https://www.ncbi.nlm.nih.gov/pubmed/34791676
http://dx.doi.org/10.1002/clc.23747

Ejemplares similares